How do you decide?' Cancer patients die waiting for CAR-T therapy

$ 20.50

5 (258) In stock

“And people are dying. About 20% of all our patients together are actually dying before they can get CAR-T,” said Krina Patel, director of the myeloma cell therapy program at MD Anderson.

CAR-T therapy: Genetically re-engineering your cells to target cancer

CAR-T cancer therapy, in rare cases, can activate latent virus - STAT

CAR-T therapies are manufactured for each individual patient

The Promise and Price of Cellular Therapies

Made-in-Canada CAR T Therapy Timeline - BioCanRx

Canadian cancer survivor works with the NRC for broader access to CAR-T therapy - National Research Council Canada

Manufacturing challenge leads to death in CAR-T trial

Oncology Data Advisor - Determining Patient Selection for CAR T-Cell Therapy

Potential solutions for manufacture of CAR T cells in cancer immunotherapy